Surgical treatment of adenocarcinoma of the esophagogastric junction and stomach
Research output: Contribution to journal › Research article › Contributed › peer-review
Contributors
Abstract
Every year about one million people worldwide are diagnosed with an adenocarcinoma of the stomach or esophagogastric junction (AEG). These tumors are among the most common causes of cancer-related deaths worldwide. Complete resection of the primary tumor in conjunction with radical lymphadenectomy is the only curative treatment for most tumor stages. The interdisciplinary approach depends on tumor stage; the surgical approach additionally on the exact tumor location and histological classification. While the risk profile and various epidemiological characteristics differ between AEG and stomach adenocarcinoma, these entities have similar precursor lesions and molecular alterations. Squamous cell carcinomas of the esophagus, however, differ in terms of etiology and molecular alterations, as well as in terms of therapeutic approaches; they therefore require a separate portrayal.
Details
Original language | English |
---|---|
Pages (from-to) | 401-406 |
Number of pages | 6 |
Journal | Gastroenterologe |
Volume | 12 |
Issue number | 5 |
Publication status | Published - Sept 2017 |
Peer-reviewed | Yes |
External IDs
Scopus | 85027518825 |
---|
Keywords
Keywords
- Barrett esophagus, Cardia, Gastrectomy, Laparoscopic surgery, Lymph node excision